Maternal use of bupropion and risk for congenital heart defects

Objective We sought to determine if maternal bupropion treatment in early pregnancy is associated with congenital heart defects in the infant. Study Design We conducted a retrospective case-control study of birth defects risk factors. Data on 6853 infants with major heart defects were compared with...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of obstetrics and gynecology 2010-07, Vol.203 (1), p.52.e1-52.e6
Hauptverfasser:	Alwan, Sura, MSc, Reefhuis, Jennita, PhD, Botto, Lorenzo D., MD, Rasmussen, Sonja A., MD, MS, Correa, Adolfo, MD, MPH, Friedman, Jan M., MD, PhD
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antidepressive Agents, Second-Generation - adverse effects Antidepressive Agents, Second-Generation - therapeutic use Biological and medical sciences birth defects Bupropion - adverse effects Bupropion - therapeutic use bupropion exposure Case-Control Studies Chi-Square Distribution congenital heart defects Female Gynecology. Andrology. Obstetrics Heart Defects, Congenital - chemically induced Humans Infant, Newborn Interviews as Topic Maternal Exposure - adverse effects Medical sciences Obstetrics and Gynecology Pregnancy Retrospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!